HGCSG1503: A retrospective cohort study evaluating the safety and efficacy of TAS-102 in patients with metastatic colorectal cancer: Analysis of GERCOR index

被引：0

作者：

Hatanaka, K. ^{[1
]}

Yuki, S. ^{[2
]}

Nakano, S. ^{[2
]}

Sawada, K. ^{[3
]}

Harada, K. ^{[4
]}

Okuda, H. ^{[5
]}

Ando, T. ^{[6
]}

Ogawa, K. ^{[7
]}

Furukawa, K. ^{[8
]}

Minami, S. ^{[9
]}

Saiki, T. ^{[10
]}

Ohta, T. ^{[11
]}

Kato, T. ^{[12
]}

Nakajima, J. ^{[13
]}

Sasaki, T. ^{[14
]}

Saitoh, S. ^{[15
]}

Shindo, Y. ^{[16
]}

Tateyama, M. ^{[17
]}

Kato, S. ^{[18
]}

Nagai, H. ^{[19
]}

Sakata, Y. ^{[20
]}

Komatsu, Y. ^{[21
]}

机构：

[1] Hakodate Municipal Hosp, Dept Gastroenterol, Hakodate, Hokkaido, Japan

[2] Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan

[3] Hokkaido Univ Hosp, Div Canc Ctr, Sapporo, Hokkaido, Japan

[4] Kushiro Rosai Hosp, Dept Med Oncol, Kushiro, Hokkaido, Japan

[5] Keiyukai Sapporo Hosp, Dept Med Oncol, Sapporo, Hokkaido, Japan

[6] Univ Toyama, Dept Gastroenterol & Hematol, Fac Med, Toyama, Japan

[7] Kouseiren Takaoka Hosp, Dept Gastroenterol, Takaoka, Toyama, Japan

[8] Niigata City Gen Hosp, Dept Gastroenterol, Niigata, Japan

[9] Oji Gen Hosp, Dept Gastroenterol, Tomakomai, Japan

[10] Teine Keijinkai Hosp, Dept Med Oncol, Sapporo, Hokkaido, Japan

[11] Sapporo Higashi Tokushukai Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan

[12] Wakkanai City Hosp, Dept Internal Med, Wakkanai, Hokkaido, Japan

[13] Obihiro Kosei Hosp, Dept Gastroenterol, Obihiro, Hokkaido, Japan

[14] Hokkaido Gastroenterol Hosp, Dept Internal Med, Sapporo, Hokkaido, Japan

[15] Misawa City Hosp, Dept Internal Med, Misawa, Japan

[16] Nakadori Gen Hosp, Dept Surg Gastroenterol, Akita, Japan

[17] Tomakomai Nisshou Hosp, Dept Internal Med, Tomakomai, Japan

[18] Sapporo Hokuyu Hosp, Dept Gastroenterol, Sapporo, Hokkaido, Japan

[19] HGCSG, Data Ctr, Sapporo, Hokkaido, Japan

[20] Misawa City Hosp, Misawa, Japan

[21] Hokkaido Univ Hosp, Div Canc Ctr, Digest Internal Med, Sapporo, Hokkaido, Japan

来源：

ANNALS OF ONCOLOGY | 2018年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P - 261

引用

页数：1

共 50 条

[41] Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer
Daisuke Kotani
Yasutoshi Kuboki
Satoshi Horasawa
Asumi Kaneko
Yoshiaki Nakamura
Akihito Kawazoe
Hideaki Bando
Hiroya Taniguchi
Kohei Shitara
Takashi Kojima
Akihito Tsuji
Takayuki Yoshino
BMC Cancer, 19
[42] Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer
Kotani, Daisuke
Kuboki, Yasutoshi
Horasawa, Satoshi
Kaneko, Asumi
Nakamura, Yoshiaki
Kawazoe, Akihito
Bando, Hideaki
Taniguchi, Hiroya
Shitara, Kohei
Kojima, Takashi
Tsuji, Akihito
Yoshino, Takayuki
BMC CANCER, 2019, 19 (01)
[43] Neutropenia as a predictive factor in patients with metastatic colorectal cancer treated with TAS-102
Hamauchi, S.
Yamazaki, K.
Masuishi, T.
Kito, Y.
Komori, A.
Tsushima, T.
Todaka, A.
Yokota, T.
Machida, N.
Fukutomi, A.
Onozawa, Y.
Muro, K.
Yasui, H.
Mori, K.
Taniguchi, H.
ANNALS OF ONCOLOGY, 2015, 26 : 50 - 51
[44] Neutropenia as a predictor of efficacy in the treatment of metastatic colorectal cancer with TAS-102 (trifluridine - tipiracil).
Rodriguez Garces, Maria Yeray
Senin, Loreto Dominguez
Urbano, Maria Amor
Tarazona, Victoria Avino
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E15564 - E15564
[45] Effectiveness of TAS-102 in patients with metastatic colorectal cancer in a single comprehensive cancer center
Sales, C.
Juliao, I.
Rosinha, A.
Marques, D.
Carneiro, F.
Faustino, C.
Machado, M.
Ferreira, P.
Fragoso, M.
Sousa, N.
ANNALS OF ONCOLOGY, 2018, 29 : 79 - 79
[46] Analysis of tumor location: A retrospective trial for evaluating the safety and efficacy of regorafenib for patients with metastatic colorectal cancer: HGCSG1401
Miyagishima, T.
Yuki, S.
Muranaka, T.
Tsuji, Y.
Ota, Y.
Hatanaka, K.
Okuda, H.
Sasaki, T.
Dazai, M.
Konno, J.
Nakamura, M.
Ohta, T.
Honda, T.
Ishiguro, A.
Muto, O.
Kato, S.
Sato, A.
Abe, M.
Sakata, Y.
Komatsu, Y.
ANNALS OF ONCOLOGY, 2017, 28
[47] Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical Data
Vitale, Pasquale
Zanaletti, Nicoletta
Famiglietti, Vincenzo
De Falco, Vincenzo
Cervantes, Andres
Rosello, Susanna
Fenocchio, Elisabetta
Milanesio, Michela
Lombardi, Pasquale
Ciardiello, Davide
Martini, Giulia
Martinelli, Erika
Ciardiello, Fortunato
Troiani, Teresa
Napolitano, Stefania
CLINICAL COLORECTAL CANCER, 2021, 20 (03) : 227 - 235
[48] Erratum to: Phase 1 study of oral TAS-102 in patients with refractory metastatic colorectal cancer
Johanna C. Bendell
Lee S. Rosen
Robert J. Mayer
Jonathan W. Goldman
Jeffrey R. Infante
Fabio Benedetti
Donghu Lin
Hirokazu Mizuguchi
Christopher Zergebel
Manish R. Patel
Cancer Chemotherapy and Pharmacology, 2016, 77 : 439 - 439
[49] Identification of biomarkers for TAS-102 efficacy in metastatic colorectal cancer patients based on preclinical analysis and clinical validation.
Suenaga, Mitsukuni
Mashima, Tetsuo
Kawata, Naomi
Dan, Shingo
Wakatsuki, Takeru
Shinozaki, Eiji
Ichimura, Takashi
Ogura, Mariko
Takahari, Daisuke
Osumi, Hiroki
Ota, Yumiko
Chin, Keisho
Seimiya, Hiroyuki
Yamaguchi, Kensei
Yamaguchi, Toshiharu
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
[50] Retrospective cohort study on the safety and efficacy of panitumumab for patients with metastatic colorectal cancer: The HGCSG1002 study-Analysis of after cetuximab refractory
Kobayashi, Yoshimitsu
Fukushima, Hiraku
Sasaki, Takahide
Yuki, Satoshi
Okuda, Hiroyuki
Kusumi, Takaya
Doi, Ayako
Tsuji, Yasushi
Hatanaka, Kazuteru
Uebayashi, Minoru
Koike, Masahiko
Kato, Takashi
Nakamura, Michio
Sato, Yasushi
Ohta, Tomoyuki
Kudo, Mineo
Konno, Jun
Iwai, Kazuhiro
Sakata, Yuh
Komatsu, Yoshito
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)

← 1 2 3 4 5 →